COMP <GO>
MANE vs RYTM // EV/EBITDA & P/E VALUATION
Veradermics Incorporated (NYSE) VS. Rhythm Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: MANE 7
— RYTM 4
■ METRIC PARITY
LAST: $129.53 (-7.27%) • MKT CAP: $5.84B
valuation
—
LAST: $93.44 (+0.94%) • MKT CAP: $6.37B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MANE VS. RYTM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MANE | RYTM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 89.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.90% | -29.60% | +17.70 | MANE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.19% | -1.82% | +0.63 | MANE | /fcf-yield <GO> |
| Operating Margin | -4.30% | -60.00% | +55.70 | MANE | /operating-margins <GO> |
| Net Profit Margin | -4.20% | -0.10% | -4.10 | RYTM | /net-margins <GO> |
| Revenue Growth (YoY) | 4.40% | 45.80% | -41.40 | RYTM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 14.33 | +11.67 | MANE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | RYTM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.4 | 50.0 | +10.40 | MANE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.96 | +0.11 | MANE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.0x | 33.0x | -9.00 | MANE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.84B | $6.37B | -$537.4M | RYTM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MANE REV | RYTM REV | MANE GROSS % | RYTM GROSS % | MANE FCF | RYTM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $202.6M | $189.8M | — | 89.7% | -$71.6M | -$116.6M |
| FY 2024 | $75.0M | $130.1M | — | 89.7% | -$23.7M | -$113.9M |
| FY 2023 | — | $77.4M | — | — | — | -$139.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MANE // BETA 1.07
RYTM // BETA 0.96